3649 results for «414»

Filter By

3649 results

Opening ceremony

08 Apr 2017 – From PCR Tokyo Valves 2017

Closing Ceremony and Awards

09 Apr 2017 – From PCR Tokyo Valves 2017

GulfPCR-GIM 2017 Opening Ceremony

13 Dec 2017 – From GulfPCR-GIM 2017

Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...

GulfPCR-GIM 2017 Opening Ceremony

GulfPCR-GIM 2017 Award and Closing Ceremony

14 Dec 2017 – From GulfPCR-GIM 2017

Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.

GulfPCR-GIM 2017: Award and Closing Ceremony

Four-Year Outcomes from the EVOLUT Low Risk Trial

26 Oct 2023

Dejan Milasinovic provides his take on the EVOLUT Low Risk trial, presented by Michael I. Reardon at TCT Congress 2023. 4-year results reveal a continuing trend towards lower combined rates of all-cause mortality and disabling stroke with TAVI compared with surgical aortic valve replacement (SAVR)

Dejan Milasinovic

Author

Dejan Milasinovic
Four-Year Outcomes from the EVOLUT Low Risk Trial

Innvolution Healthcare reports one-year findings from the ALCHEMY study evaluating Eternia in 1000 patients at EuroPCR 2026

27 May 2026

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial
Didn’t find what you were looking for?